Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 45

1.

Fungal infections: their diagnosis and treatment in transplant recipients.

Van Thiel DH, George M, Moore CM.

Int J Hepatol. 2012;2012:106923. doi: 10.1155/2012/106923. Epub 2012 Aug 26.

2.

[Prevention and treatment of febrile neutropenia].

Montemurro F, Gallicchio M, Aglietta M.

Tumori. 1997;83(2 Suppl):S15-9. Review. Italian.

PMID:
9235724
3.

Antifungal prophylaxis in immunocompromised hosts.

Reents S, Goodwin SD, Singh V.

Ann Pharmacother. 1993 Jan;27(1):53-60. Review.

PMID:
8431623
4.

Antifungal agents for preventing fungal infections in solid organ transplant recipients.

Playford EG, Webster AC, Sorell TC, Craig JC.

Cochrane Database Syst Rev. 2004;(3):CD004291. Review.

PMID:
15266524
5.

[Role of anidulafungin in solid organ transplant recipients].

Aguado JM, Ayats J.

Enferm Infecc Microbiol Clin. 2008 Dec;26 Suppl 14:29-34. Review. Spanish.

PMID:
19572432
6.

Liposomal amphotericin B: a review of its use as empirical therapy in febrile neutropenia and in the treatment of invasive fungal infections.

Moen MD, Lyseng-Williamson KA, Scott LJ.

Drugs. 2009;69(3):361-92. doi: 10.2165/00003495-200969030-00010. Review.

PMID:
19275278
7.
8.

The cost of treating systemic fungal infections.

van Gool R.

Drugs. 2001;61 Suppl 1:49-56. Review.

PMID:
11219550
9.

Prophylactic antifungal agents used after lung transplantation.

Marino E, Gallagher JC.

Ann Pharmacother. 2010 Mar;44(3):546-56. doi: 10.1345/aph.1M377. Epub 2010 Feb 23. Review.

PMID:
20179260
10.

Antifungal agents for preventing fungal infections in non-neutropenic critically ill patients.

Cortegiani A, Russotto V, Maggiore A, Attanasio M, Naro AR, Raineri SM, Giarratano A.

Cochrane Database Syst Rev. 2016 Jan 16;(1):CD004920. doi: 10.1002/14651858.CD004920.pub3. Review.

PMID:
26772902
11.

Primary antifungal prophylaxis in adult hematopoietic stem cell transplant recipients: current therapeutic concepts.

McCoy D, Depestel DD, Carver PL.

Pharmacotherapy. 2009 Nov;29(11):1306-25. doi: 10.1592/phco.29.11.1306. Review.

PMID:
19857148
12.

Prophylactic systemic antifungal agents to prevent mortality and morbidity in very low birth weight infants.

Clerihew L, Austin N, McGuire W.

Cochrane Database Syst Rev. 2007 Oct 17;(4):CD003850. Review. Update in: Cochrane Database Syst Rev. 2013;4:CD003850.

PMID:
17943803
13.

Systematic review and meta-analysis of antifungal agents for preventing fungal infections in liver transplant recipients.

Playford EG, Webster AC, Sorrell TC, Craig JC.

Eur J Clin Microbiol Infect Dis. 2006 Sep;25(9):549-61. Review.

PMID:
16912905
14.

Invasive fungal infections in liver transplantation.

Liu X, Ling Z, Li L, Ruan B.

Int J Infect Dis. 2011 May;15(5):e298-304. doi: 10.1016/j.ijid.2011.01.005. Epub 2011 Feb 22. Review.

15.

Posaconazole: Use in the Prophylaxis and Treatment of Fungal Infections.

Clark NM, Grim SA, Lynch JP 3rd.

Semin Respir Crit Care Med. 2015 Oct;36(5):767-85. doi: 10.1055/s-0035-1562902. Epub 2015 Sep 23. Review.

PMID:
26398542
16.

Prophylaxis, pre-emptive or empirical antifungal therapy: which is best in non-lung transplant recipients?

Salavert M.

Int J Antimicrob Agents. 2008 Nov;32 Suppl 2:S149-53. doi: 10.1016/S0924-8579(08)70017-7. Review.

PMID:
19013340
17.

Basiliximab: a review of its use as induction therapy in renal transplantation.

Chapman TM, Keating GM.

Drugs. 2003;63(24):2803-35. Review.

PMID:
14664658
18.

Emerging issues with diagnosis and management of fungal infections in solid organ transplant recipients.

Farmakiotis D, Kontoyiannis DP.

Am J Transplant. 2015 May;15(5):1141-7. doi: 10.1111/ajt.13186. Epub 2015 Feb 5. Review.

19.

Mitoxantrone: a review of its use in multiple sclerosis.

Scott LJ, Figgitt DP.

CNS Drugs. 2004;18(6):379-96. Review.

PMID:
15089110
20.

Managing fungal and viral infection in the immunocompromised host.

Jehn U.

Recent Results Cancer Res. 1988;108:61-70. Review.

PMID:
3051213

Supplemental Content

Support Center